2,2'-脱水-1-β-D-阿拉伯呋喃糖基-5-氟胞嘧啶对腹腔内和脑内接种小鼠白血病的口服及肠胃外活性。 - Suppr | 超能文献

Oral and parenteral activity of 2,2'-anhydro-1- -D-arabinofuranosyl-5-fluorocytosine against both intraperitoneally and intracerebrally inoculated mouse leukemia.

作者信息

Fox J J, Falco E A, Wempen I, Pomeroy D, Dowling M D, Burchenal J H

出版信息

Cancer Res. 1972 Oct;32(10):2269-72.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Oral and parenteral activity of 2,2'-anhydro-1- -D-arabinofuranosyl-5-fluorocytosine against both intraperitoneally and intracerebrally inoculated mouse leukemia.2,2'-脱水-1-β-D-阿拉伯呋喃糖基-5-氟胞嘧啶对腹腔内和脑内接种小鼠白血病的口服及肠胃外活性。

Cancer Res. 1972 Oct;32(10):2269-72.

2

Synergistic effects of the combination of cis-platinum diamminodichloride and 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in transplanted mouse leukemias.

Cancer Res. 1977 Nov;37(11):4098-100.

3

Antitumor activity of 5-formamido-1- D-ribofuranosylthioimidazole-4-carboxamide 2',3',5'-triformate in a variety of animal tumors.5-甲酰胺基-1-D-呋喃核糖硫代咪唑-4-甲酰胺2',3',5'-三甲酸酯在多种动物肿瘤中的抗肿瘤活性

Cancer Chemother Rep. 1971 Jun;55(3):229-31.

4

Enhancement by tetrahydrouridine of 1-beta-D-arabinofuranosylcytosine (cytarabine) oral activity in L1210 leukemic mice.四氢尿苷对L1210白血病小鼠中1-β-D-阿拉伯呋喃糖基胞嘧啶（阿糖胞苷）口服活性的增强作用。

Cancer Res. 1970 Aug;30(8):2166-72.

5

Influence of antileukemic (L1210) treatment schedule on disposition of (minus)-emetine hydrochloride (NSC 33669) in normal and leukemic mice.抗白血病（L1210）治疗方案对正常和白血病小鼠体内盐酸（-）-吐根碱（NSC 33669）处置的影响。

Cancer Res. 1974 Jul;34(7):1581-5.

6

[Possibility of utilizing lymphatic leukemia L1210 as a first screening model in the primary selection of new antitumor antibiotics].[利用淋巴白血病L1210作为新型抗肿瘤抗生素初步筛选的首个筛选模型的可能性]

Antibiotiki. 1974 Aug;19(8):679-84.

7

Combined effects of chemotherapy and immunity against leukemia L1210 in DBA-2 mice.化疗与免疫对DBA - 2小鼠白血病L1210的联合作用。

Cancer Res. 1969 Apr;29(4):848-54.

8

The antitumor activity of certain substituted nucleosides.某些取代核苷的抗肿瘤活性。

Pol J Pharmacol Pharm. 1976;28(5):403-9.

9

Clinical pharmacology of 1-beta-d-arabinofuranosyl cytosine.1-β-D-阿拉伯呋喃糖基胞嘧啶的临床药理学

Clin Pharmacol Ther. 1971 Nov-Dec;12(6):944-54. doi: 10.1002/cpt1971126944.

10

The effect of dose interval on the survival of L1210 leukemic mice treated with DNA synthesis inhibitors.

Cancer Res. 1973 Apr;33(4):895-901.

引用本文的文献

1

A comparative study of the effects of cyclocytidine and norepinephrine on renin and esterase release from mouse submandibular gland.环胞苷与去甲肾上腺素对小鼠颌下腺肾素和酯酶释放影响的比较研究。

Naunyn Schmiedebergs Arch Pharmacol. 1983 Jun;323(1):37-44. doi: 10.1007/BF00498825.

2

Antitumor activity and pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate: an orally active derivative of 1-beta-D-arabinofuranosylcytosine.1-β-D-阿拉伯呋喃糖基胞嘧啶-5'-硬脂酰磷酸酯的抗肿瘤活性与药理学：1-β-D-阿拉伯呋喃糖基胞嘧啶的一种口服活性衍生物

Jpn J Cancer Res. 1989 Jul;80(7):679-85. doi: 10.1111/j.1349-7006.1989.tb01696.x.

3

Antiviral activities of acyl derivatives of 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosylcytosine in cell culture.2,2'-脱水-1-β-D-阿拉伯呋喃糖基胞嘧啶和1-β-D-阿拉伯呋喃糖基胞嘧啶的酰基衍生物在细胞培养中的抗病毒活性。

Antimicrob Agents Chemother. 1977 Feb;11(2):191-7. doi: 10.1128/AAC.11.2.191.